Tissue confirmation of presumptive stage i sarcoidosis

Journal of Bronchology and Interventional Pulmonology

Volumn 20, Issue 2, 2013, Pages 103-105

  Reich, Jerome M ^a  

^a EARLE A CHILES RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL DECISION MAKING; LYMPHADENOPATHY; MORBIDITY; PAPANICOLAOU TEST; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; STAGE I SARCOIDOSIS; TISSUE MICROARRAY;

HUMANS; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX;

EID: 84877888537     PISSN: 19446586     EISSN: 19488270     Source Type: Journal    
DOI: 10.1097/LBR.0b013e31828f93f9     Document Type: Review

References (6)

1. Kassirer JP. Our stubborn quest for diagnostic certainty: a cause of excessive testing [editorial]. N Engl J Med. 1989;320:1489-1491.
2. Winterbauer RH, Belic N, Moores KD. A clinical interpretation of bilateral hilar adenopathy. Ann Intern Med. 1973;78:65-71.
3. Reich JM, Brouns MC, O'Connor EA, et al. Mediastinoscopy in patients with presumptive stage I sarcoidosis: a risk/benefit, cost/benefit analysis. Chest. 1998; 113:147-153.
4. Boujaoude Z, Dahdel M, Pratter M, et al. Endobronchial ultrasound with transbronchial needle aspiration in the diagnosis of bilateral hilar and mediastinal lymphadenopathy. J Bronchol. Interv Pulmonol. 2012;19: 19-23.
5. Statement on sarcoidosis: joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736-755.
6. Carr PL, Singer DE, Goldenheim P, et al. Noninvasive testing of asymptomatic bilateral hilar adenopathy. J Gen Intern Med. 1990;5:138-146.